Patent · US Active

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

US7993866B2 · kind B2 · utility

3Cited by
9References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 12, 2009
Grant dateAug 9, 2011
Priority date
Expiry dateJan 12, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S436/811
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.